Dr

182 email addresses found for drreddys.com
{first}@drreddys.com
182 email addresses
http://asianhhm.com/pressreleases/dr-reddy-s-laboratories-ltd-receives-fda-approval-for-zembrace-symtouch-sumatriptan-succinate-injection-for-the-acute-treatment-of-migraines-in-adults November 11, 2016
http://bioportfolio.com/news/article/3307436/promius-pharma-to-present-3-posters-including-a-podium-presentation-from-mast.html October 10, 2017
http://biospace.com/article/releases/dr-reddy-s-laboratories-ltd-breathes-new-life-into-doan-s-in-new-marketing-campaign- October 10, 2017
http://biospace.com/article/releases/promius-pharma-llc-presents-positive-results-for-phase-ii-study-of-dfn-02-a-novel-intranasal-formulation-of-sumatriptan-at-b-18th-congress-of-the- November 11, 2017
http://businesswire.com/news/home/20171130006331/en/dr.-reddy%e2%80%99s-announces-approval-impoyz%e2%84%a2-clobetasol-propionate July 7, 2018
http://directory.targetmarketingmag.com/company/59430/news/1942138/promius-pharma-employees-band-together-to-fundraise-for-hurricane-victims January 1, 2018
http://markets.businessinsider.com/news/stocks/announcing-progress-in-dermatological-research-promius-pharma-shares-9-posters-at-fall-clinical-dermatology-conference-1004148989 December 12, 2017
http://markets.businessinsider.com/news/stocks/promius-pharma-announces-zembrace-symtouch-sumatriptan-injection-3-mg-achieves-primary-endpoint-in-post-approval-clinical-trial-1008139858 December 12, 2018
http://markets.businessinsider.com/news/stocks/promius-pharma-employees-band-together-to-fundraise-for-hurricane-victims-1007876623 September 9, 2018
http://marketwatch.com/press-release/promius-pharma-announces-launch-of-my-skin-matters-an-empowerment-movement-for-people-with-skin-conditions-2018-10-29 December 12, 2018
http://medindia.net/health-press-release/progress-in-migraine-research-promius-announces-presentations-for-the-70th-american-academy-of-neurology-annual-meeting-366641-1.htm October 10, 2018
http://medindia.net/health-press-release/promius-pharma-announces-migraine-presentations-at-the-60th-annual-scientific-meeting-of-the-american-headache-society-375297-1.htm December 12, 2018
http://medindia.net/health-press-release/promius-pharma-announces-positive-results-for-phase-2-study-of-dfn-02-a-novel-intranasal-formulation-of-sumatriptan-330179-1.htm July 7, 2018
http://medindia.net/health-press-release/promius-pharma-dermatology-marketing-team-named-2018-pm360-elite-100-winner-371344-1.htm October 10, 2018
http://medindia.net/health-press-release/promius-pharma-initiates-phase-3-clinical-trials-of-dfd-03-for-the-treatment-of-acne-vulgaris-348204-1.htm November 11, 2018
http://pharmalive.com/promius-pharma-launches-new-corporate-brand-identity December 12, 2018
http://presentationmaster.digitalmedianet.com/article/progress-in-migraine-research-promius-announces-presentations-for-the-70th-american-academy-of-neurology-annual-meeting-5374521 April 4, 2018
http://prnewswire.com/news-releases/migraine-research-team-including-dr-sagar-munjal-and-dr-alix-bennett-of-promius-pharma-honored-at-ahs-2017-with-the-harold-g-wolff-lecture-award-300471418.html September 9, 2017
http://prnewswire.com/news-releases/promius-pharma-announces-positive-results-for-phase-2-study-of-dfn-02-a-novel-intranasal-formulation-of-sumatriptan-300470376.html October 10, 2017
http://prnewswire.com/news-releases/promius-pharma-initiates-phase-3-clinical-trials-of-dfd-03-for-the-treatment-of-acne-vulgaris-300552470.html December 12, 2018
http://prnewswire.com/news-releases/promius-pharma-launches-notime4migraines-an-online-resource-about-migraine-symptoms-and-potential-treatment-options-300317406.html August 8, 2017
http://prnewswire.com/news-releases/promius-pharma-launches-no-time-4-migraines-psa-to-educate-patients-and-caregivers-during-migraine-awareness-month-300478760.html October 10, 2017
http://qlifepro.com/press/20160419-18-26632/nj-dr-reddys-2 March 3, 2017
http://qlifepro.com/press/20171201-15-32862/nj-dr-reddys-labs-4 March 3, 2018
http://stage.uspharmacist.com/article/promius-pharma-initiates-phase-3-clinical-trials-of-dfd03-for-the-treatment-of-acne-vulgaris August 8, 2018
http://uspharmacist.com/article/promius-pharma-initiates-phase-3-clinical-trials-of-dfd03-for-the-treatment-of-acne-vulgaris September 9, 2018
Show more results
172 more results for drreddys.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about drreddys.com

Language of the website: English